CASE CLOSING MEMORANDUM

• Document Type: FOIA
• Collection: FOIA Collection
• Document Number (FOIA) /ESDN (CREST): 06909877
• Release Decision: RIPPUB
• Original Classification: U
• Document Page Count: 1
• Document Creation Date: March 28, 2024
• Document Release Date: February 27, 2024
• Case Number: F-2015-00558
• Publication Date: October 17, 2013

Approved for Release: 2024/02/27 C06909877
�
(b)(3)
(b)(6)
(b)(7)(c)
.szcarh-T-471-tie�Ftnacr
�
Office of Inspector General
Investigations Staff
Case Closing Memorandum
Administrative Data
(b)(3)
Case Title:
Case No.:
Investigator:
Supervisor:
Date Received:
23 August 2013
Date Opened:
(b)(3)
Date Assigned:
29 August 2013
Case Type:
(b)(6)
(b)(7)(c)
H. Summary of Investigative Actions
(b)(1)
(b)(3)
(b)(3)
(b)(6)
(b)(7)(c)
(b)(3)
(b)(3)
(b)(1)
(b)(3)
(b)(6)
(b)(7)(c)
Use of Gov Sys to Order Steroids
SAC
(b)(3)
(b)(6)
(b)(7)(c)
23 August 2013
Preliminary Investigation
(b)(1)
(b)(3)
1. (nSONIFTOn 23 August 2013, Office of Inspector General (OIG
Charge (ASAC: reviewed the logfiles for
review ASAC discovered that on 14 August 2013, IP address
called Var 10 from
AnVar 10 from
cial Agent in
During his
rdered a product
On 15 August 2013, the same IP address ordered a product called
Assistant S
Review of the IP address demonstrated its association with
(b)(3)
2. (U11_511.terOn 23 August 2013, the OIG initiated a preliminary investigation (PI) into the
matter. During the course of the PI the reporting agent reviewed the websites and the specific items
ordered. The websites identify on the homepage of each that the sites "are offering this very strong
alternative to the highly toxic drug listed at the top of the page." identifies Var 10 as
associated with the drug oxantrione. A review of the ingredient label for AnVar 10 demonstrated the
ingredients as primarily arginine hydrochloride (HCL), multiple amino acids, and vitamin B-6.
III. Findings
3. (UHLLA:511) The OIG Investigation determined that the products ordered by IP address
were not schedule LH controlled substances. Neither the products nor their ingredients are
listed in 21 USC � 802(41)(A) Definitions for steroid associated controlled substances. The investigation
also notes that the sites identify that these substances are not "drugs" and are alternatives to actual
steroids. This matter is considered closed by OIG.
IV. Review and Approval
Case Closing Memo submitted by Investigator to
Supervisor:
Case Closing Memo approved by Supervisor:
(b)(3)
(b)(6)
(b)(7)(c)
(b)(3)
(b)(6)
(b)(7)(c)
(b)(3)
(b)(1)
(b)(3)
(b)(6)
(b)(7)(c)
10/1-4i2-4
INV-201
Page 1 of 1
This document is controlled by the CIA/OIG and neither the document nor its contents should be
disseminated without nrior IG authorization.
(b)(3)
(b)(3)
.S.E.CRET.4-4149�Pettlq�
Approved for Release: 2024/02/27 C06909877